News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,547 Results
Type
Article (3199)
Company Profile (6)
Press Release (70342)
Section
Business (18802)
Career Advice (23)
Deals (3406)
Drug Delivery (1)
Drug Development (9027)
Employer Resources (3)
FDA (3204)
Job Trends (1453)
News (34082)
Policy (2740)
Tag
Academia (304)
Adcomms (2)
Allergies (1)
Alliances (4073)
ALS (2)
Alzheimer's disease (21)
Antibody-drug conjugate (ADC) (15)
Approvals (3208)
Artificial intelligence (16)
Bankruptcy (28)
Best Places to Work (1322)
Biosimilars (5)
Biotechnology (3)
Bladder cancer (26)
Brain cancer (10)
Breast cancer (50)
Cancer (506)
Cardiovascular disease (11)
Career advice (23)
CAR-T (10)
Cell therapy (30)
Cervical cancer (7)
Clinical research (7465)
Collaboration (63)
Compensation (15)
COVID-19 (129)
C-suite (13)
Cystic fibrosis (1)
Data (309)
Depression (1)
Diabetes (16)
Diagnostics (409)
Digital health (3)
Drug discovery (6)
Duchenne muscular dystrophy (3)
Earnings (9092)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (10528)
Executive appointments (54)
FDA (3415)
Funding (61)
Gene therapy (20)
GLP-1 (47)
Government (296)
Guidances (7)
Healthcare (3098)
Huntington's disease (1)
Immunology and inflammation (10)
Indications (3)
Infectious disease (130)
Inflammatory bowel disease (11)
Influenza (1)
Intellectual property (6)
Interviews (2)
IPO (1513)
Job creations (170)
Job search strategy (22)
Kidney cancer (4)
Layoffs (34)
Legal (453)
Liver cancer (32)
Lung cancer (80)
Lymphoma (13)
Management (2)
Manufacturing (8)
MASH (1)
Medical device (4280)
Medtech (4281)
Mergers & acquisitions (1937)
Metabolic disorders (27)
Multiple sclerosis (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (1)
Neuroscience (44)
NextGen: Class of 2025 (789)
Non-profit (291)
Now hiring (1)
Obesity (10)
Opinion (4)
Ovarian cancer (14)
Pain (28)
Pancreatic cancer (31)
Parkinson's disease (11)
Patents (23)
Patient recruitment (11)
People (4743)
Pharmaceutical (1)
Phase I (2850)
Phase II (3399)
Phase III (2338)
Pipeline (138)
Postmarket research (183)
Preclinical (988)
Prostate cancer (21)
Radiopharmaceuticals (19)
Rare diseases (13)
Real estate (348)
Regulatory (2229)
Reports (4)
Research institute (247)
Schizophrenia (3)
Series A (9)
Series B (6)
Service/supplier (1)
Sickle cell disease (1)
Spinal muscular atrophy (1)
Sponsored (3)
Startups (290)
Stomach cancer (3)
Supply chain (2)
Vaccines (46)
Venture capitalists (3)
Weight loss (4)
Women's health (7)
Date
Today (13)
Last 7 days (121)
Last 30 days (297)
Last 365 days (3598)
2025 (1177)
2024 (3966)
2023 (4956)
2022 (8420)
2021 (7776)
2020 (6496)
2019 (5252)
2018 (3971)
2017 (4038)
2016 (3526)
2015 (3933)
2014 (2710)
2013 (2259)
2012 (2360)
2011 (2297)
2010 (1997)
Location
Africa (25)
Alabama (2)
Alaska (2)
Arizona (16)
Asia (4237)
Australia (527)
California (567)
Canada (162)
China (61)
Colorado (30)
Connecticut (16)
Delaware (16)
Europe (8105)
Florida (145)
Georgia (68)
Idaho (10)
Illinois (92)
India (2)
Indiana (32)
Japan (10)
Kansas (8)
Maryland (80)
Massachusetts (398)
Michigan (39)
Minnesota (65)
Missouri (24)
Montana (12)
Nebraska (6)
Nevada (6)
New Hampshire (9)
New Jersey (207)
New Mexico (2)
New York (179)
North Carolina (108)
Northern California (220)
Ohio (25)
Oklahoma (2)
Oregon (6)
Pennsylvania (145)
Rhode Island (8)
South America (43)
South Carolina (3)
Southern California (235)
Tennessee (35)
Texas (133)
United States (2505)
Utah (16)
Virginia (15)
Washington State (29)
West Virginia (1)
Wisconsin (6)
73,547 Results for "checkpoint surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
Press Releases
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
March 31, 2025
·
18 min read
GLP-1
GLP-1 Drug Boom Recalls the Rise of PD-1 Checkpoint Inhibitors
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences suggest history may not repeat itself.
March 19, 2025
·
8 min read
·
Ben Hargreaves
Press Releases
SparX to Present Phase 1 Clinical Updates of SPX-303, a Dual Checkpoint Bispecific Antibody, at Two Events During AACR 2025
April 18, 2025
·
3 min read
Press Releases
Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
April 29, 2025
·
6 min read
Press Releases
Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
March 19, 2025
·
7 min read
Press Releases
Data from First-in-Human Trial targeting CISH, a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Cancer Presented at 2025 American Association for Cancer Research (AACR) Annual Meeting
May 2, 2025
·
5 min read
Press Releases
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
April 25, 2025
·
8 min read
Stomach cancer
FDA Sets Adcomm Meeting to Assess Checkpoint Inhibitors in Stomach Cancer Using PD-L1
The Oncologic Drugs Advisory Committee in a Sept. 26 meeting will discuss whether the regulator should restrict approval of checkpoint inhibitors based on PD-L1 expression levels.
August 23, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Virion Therapeutics Reports Positive Clinical Data with VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure, at APASL 2025 Global Liver Meeting
March 31, 2025
·
6 min read
1 of 7,355
Next
